Clinical Trials Logo

Seizures clinical trials

View clinical trials related to Seizures.

Filter by:

NCT ID: NCT00975715 Completed - Clinical trials for Partial Onset Seizures

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study is designed to provide short term efficacy and safety data of TRI476 in children with inadequately-controlled partial seizures. Patients will be randomized into either drug treatment or placebo group at 1:1 ratio, and receive their respective treatment for 8 weeks. The purpose of study is to confirm that TRI476 as adjunctive therapy is effective and safe.

NCT ID: NCT00955357 Completed - Partial Epilepsies Clinical Trials

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Start date: August 2009
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.

NCT ID: NCT00946751 Completed - Seizure Clinical Trials

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

Start date: March 2004
Phase: Phase 1
Study type: Interventional

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

NCT ID: NCT00938431 Completed - Epilepsy Clinical Trials

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Start date: November 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the safety and pharmacokinetics of LCM syrup in children ages from 1 month to 17 years with uncontrolled partial seizures when added to 1 to 3 other antiepileptic drugs (AEDs).

NCT ID: NCT00914680 Completed - Bipolar Depression Clinical Trials

Berlin Magnetic Seizure Therapy Depression Trial 01

Start date: June 2009
Phase: Phase 3
Study type: Interventional

This treatment pilot study will investigate clinical efficacy and adverse effects of magnetic seizure therapy (MST) in patients currently experiencing a unipolar or bipolar depressive episode. The investigators will perform add-on tests to assess clinical and cognitive response to treatment. It is hypothesized that MST will have an antidepressant efficacy with a beneficial neurocognitive adverse effect profile.

NCT ID: NCT00903786 Completed - Clinical trials for Refractory Partial Seizures

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

Start date: June 17, 2009
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to investigate the safety and tolerability of perampanel in long- term treatment in the patients with refractory partial epilepsy (uncontrolled with other anti-epileptic drugs) who completed Week 10 of Phase II Study E2007-J081-231 study.

NCT ID: NCT00887861 Completed - Epilepsy Clinical Trials

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

Start date: March 2009
Phase: Phase 2
Study type: Interventional

This study will asses the safety and efficacy of BGG492 in reducing the seizure rate in therapy-refractory partial seizures.

NCT ID: NCT00884351 Completed - Seizures Clinical Trials

Magnetoencephalography in Absence Seizures

Start date: April 15, 2009
Phase: N/A
Study type: Observational

Background: - An absence seizure is a type of seizure that usually begins in childhood and goes away by early adulthood. Scientists do not yet know where absence seizures begin in the brain. Some evidence suggests that these seizures begin in the thalamus, a structure deep in the brain, but other studies suggest that they begin in the frontal cortex, at the front part of the brain. - Magnetoencephalography is a type of brain scanning procedure that is useful in determining information about what happens to the brain during epileptic seizures. Understanding where absence seizures come from may help doctors find new treatments for them. Objectives: - To gain a better understanding of which parts of the brain are affected in absence seizures. Eligibility: - Patients 7 to 35 years of age who have been diagnosed with absence seizures. Design: - Procedures are for research purposes only, not to diagnose or treat a particular medical condition. - Two outpatient visits to the National Institutes of Health Clinical Center: evaluation and scanning. - Researchers will evaluate potential participants with a medical history, physical examination, and electroencephalography (EEG). These tests will be performed under another protocol, 01-N-0139. - Patients will undergo magnetoencephalography (MEG) and magnetic resonance imaging (MRI) of the brain. The study procedures will be performed one time; however, an MEG or MRI scan may need to be repeated for technical reasons. Researchers will not do more than two MEG or MRI scans. - The MEG will record very small magnetic field changes produced by the activity of the brain. An EEG will be recorded at the same time as the MEG. - The MRI will use a magnetic field to take pictures of the inside of the brain. - The MEG will take 3 hours to complete (2 hours for preparation, 1 hour in the scanner). The MRI will take approximately 1 hour.

NCT ID: NCT00884052 Completed - Seizures Clinical Trials

Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures

Keppra
Start date: April 2007
Phase: Phase 1/Phase 2
Study type: Interventional

The hypothesis is that a loading dose of 20 mg/kg and a maintenance dose of 5 mg/kg of Levetiracetam is going to be safe and effective in the treatment of seizures in neonates.

NCT ID: NCT00880204 Completed - Asthma Clinical Trials

Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training

Start date: May 1, 2009
Phase: N/A
Study type: Interventional

The aim of the proposed study is to determine if specific training in management of general, obstetric, neonatal and pediatric emergencies results in a change in practice of doctors working in emergency departments of public sector hospitals in three districts of Pakistan. The overall goal of the proposed study is to test the ability of a standard course (5-days training) to promote the provision of effective and evidence based practices in public sector hospital settings.